News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,891 Results
Type
Article (77940)
Company Profile (719)
Press Release (775200)
Multimedia
Podcasts (223)
Webinars (34)
Section
Business (228765)
Career Advice (3808)
Deals (39421)
Drug Delivery (172)
Drug Development (89933)
Employer Resources (207)
FDA (18270)
Job Trends (17254)
News (390167)
Policy (39055)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3043)
Academic (2)
Accelerated approval (50)
Adcomms (39)
Allergies (185)
Alliances (56293)
ALS (224)
Alzheimer's disease (1940)
Antibody-drug conjugate (ADC) (499)
Approvals (18558)
Artificial intelligence (777)
Autoimmune disease (318)
Automation (60)
Bankruptcy (404)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (238)
Biotechnology (447)
Bladder cancer (195)
Brain cancer (81)
Breast cancer (793)
Cancer (6159)
Cardiovascular disease (527)
Career advice (3274)
Career pathing (49)
CAR-T (363)
CDC (75)
Celiac Disease (3)
Cell therapy (1005)
Cervical cancer (49)
Clinical research (77159)
Collaboration (2260)
Company closure (8)
Compensation (1433)
Complete response letters (102)
COVID-19 (3029)
CRISPR (119)
C-suite (1202)
Cystic fibrosis (164)
Data (8066)
Decentralized trials (3)
Denatured (84)
Depression (186)
Dermatology (88)
Diabetes (631)
Diagnostics (7508)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (372)
Drug pricing (243)
Drug shortages (39)
Duchenne muscular dystrophy (305)
Earnings (99769)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (136665)
Executive appointments (1162)
FDA (22145)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1844)
Gene editing (263)
Generative AI (79)
Gene therapy (824)
GLP-1 (1246)
Government (5514)
Grass and pollen (8)
Guidances (413)
Healthcare (21080)
HIV (88)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (346)
Immuno-oncology (104)
Indications (192)
Infectious disease (3401)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (298)
Interviews (749)
IPO (17884)
IRA (61)
Job creations (4987)
Job search strategy (2636)
JPM (73)
Kidney cancer (21)
Labor market (112)
Layoffs (675)
Leadership (50)
Legal (9978)
Liver cancer (107)
Longevity (34)
Lung cancer (807)
Lymphoma (440)
Machine learning (63)
Management (66)
Manufacturing (1140)
MASH (205)
Medical device (15208)
Medtech (15335)
Mergers & acquisitions (22790)
Metabolic disorders (1688)
mRNA (249)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (471)
Neuropsychiatric disorders (125)
Neuroscience (3587)
Neurotech (1)
NextGen: Class of 2026 (7663)
Non-profit (5137)
Now hiring (79)
Obesity (821)
Opinion (367)
Ovarian cancer (227)
Pain (274)
Pancreatic cancer (315)
Parkinson's disease (387)
Partnered (37)
Patents (622)
Patient recruitment (701)
Peanut (67)
People (66590)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23866)
Phase 2 (33650)
Phase 3 (25334)
Pipeline (8892)
Policy (385)
Postmarket research (3286)
Preclinical (10577)
Press Release (72)
Prostate cancer (315)
Psychedelics (68)
Radiopharmaceuticals (351)
Rare diseases (1201)
Real estate (7222)
Recruiting (81)
Regulatory (29372)
Reports (77)
Research institute (2758)
Resumes & cover letters (593)
Rett syndrome (40)
RNA editing (27)
RSV (98)
Schizophrenia (191)
Series A (315)
Series B (227)
Service/supplier (27)
Sickle cell disease (121)
Special edition (31)
Spinal muscular atrophy (188)
Sponsored (55)
Startups (4266)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (135)
Vaccines (1264)
Venture capital (123)
Weight loss (566)
Women's health (129)
Worklife (24)
Date
Today (217)
Last 7 days (977)
Last 30 days (3834)
Last 365 days (32739)
2026 (13228)
2025 (32656)
2024 (37903)
2023 (42563)
2022 (53927)
2021 (58719)
2020 (57663)
2019 (51314)
2018 (39093)
2017 (36854)
2016 (37794)
2015 (43817)
2014 (38553)
2013 (34691)
2012 (36538)
2011 (36589)
2010 (36122)
Location
Africa (1224)
Alabama (101)
Alaska (7)
Arizona (370)
Arkansas (16)
Asia (50480)
Australia (8674)
California (13773)
Canada (3846)
China (1450)
Colorado (596)
Connecticut (607)
Delaware (420)
Europe (115504)
Florida (2042)
Georgia (450)
Hawaii (4)
Idaho (68)
Illinois (1159)
India (97)
Indiana (638)
Iowa (25)
Japan (554)
Kansas (140)
Kentucky (56)
Louisiana (46)
Maine (88)
Maryland (1679)
Massachusetts (10062)
Michigan (406)
Minnesota (767)
Mississippi (7)
Missouri (161)
Montana (37)
Nebraska (30)
Nevada (149)
New Hampshire (92)
New Jersey (3672)
New Mexico (34)
New York (3613)
North Carolina (1862)
North Dakota (11)
Northern California (6813)
Ohio (427)
Oklahoma (26)
Oregon (53)
Pennsylvania (2733)
Puerto Rico (30)
Rhode Island (53)
South America (1587)
South Carolina (87)
South Dakota (2)
Southern California (5388)
Tennessee (217)
Texas (2211)
United States (49266)
Utah (413)
Vermont (1)
Virginia (357)
Washington D.C. (88)
Washington State (1130)
West Virginia (4)
Wisconsin (151)
Wyoming (2)
853,891 Results for "procter and gamble co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Model Medicines to Present Evidence of First Direct-Acting Antiviral Potent Against HCV, HBV, HDV, and Co-Infections at CROI 2026
Over 300 million patients are infected with HCV, HBV, HDV, and their co-infections. MDL-001 is the first oral small molecule to demonstrate potent, direct-acting antiviral activity across all three viruses and their co-infections.
February 18, 2026
·
1 min read
Press Releases
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
April 21, 2026
·
4 min read
Press Releases
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
April 14, 2026
·
1 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs
July 9, 2025
·
2 min read
Press Releases
Omeza announces closing of $8.5 Million Series A financing co-led by Astanor and BluKap Ventures, with participation from Catalyst Investments
Round positions Omeza to accelerate clinical development and scale nationwide commercialization of its FDA-cleared regenerative wound care platform
April 21, 2026
·
1 min read
Press Releases
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
March 13, 2026
·
4 min read
Press Releases
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
April 30, 2026
·
1 min read
Press Releases
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million
May 12, 2026
·
1 min read
Press Releases
Younet AI Partners with Perpetuals.com to License and Co-Develop Forgentiq.ai Sovereign LLM and Agentic Technology Platform
Strategic Partnership Positions Both Companies at the Forefront of Institutional-Grade Digital Asset Market Infrastructure Anthropic-Broadcom Landmark Deal Securing 3.5 Gigawatts of TPU Capacity Validates the AI Infrastructure Thesis and Confirms Announced Today Vision of Enterprise-Grade Private AI as the Defining Asset Class of This Decade
April 10, 2026
·
7 min read
1 of 85,390
Next
